Sebia S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sebia S.A. - overview
Established
1967
Location
Evry, -, France
Primary Industry
Medical Devices & Equipment
About
Founded in 1967 and based in Lisses, France, Sebia S. A. manufactures and distributes clinical protein electrophoresis equipment and in-vitro diagnostic testing technology (reagents). In October 2025, Warburg Pincus acquired a minority stake in Sebia S.
A. from CVC Capital Partners. The deal is expected to close in Q1 of 2026, subject to regulatory approvals. The company provides clinical protein electrophoresis equipment and reagents, which is a technology used in in-vitro diagnostic testing.
The firm's systems analyze proteins to screen and monitor a variety of diseases and conditions, primarily oncology (multiple myeloma), metabolic disorders such as diabetes, hemoglobinopathy, and rare pathologies.
Current Investors
CDPQ, CVC, Tethys Invest
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment
Website
www.sebia.com
Verticals
HealthTech, Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Sebia S.A. - timeline of key events
Sebia S.A. - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 125,111,182 | 139,956,232 | 36,381,663 | 161,175,323 | 169,442,129 | 192,546,737 | - | - | - |
| % Revenue Growth (YoY) | - | 11.9% | - | - | - | - | - | - | - |
| EBITDA (USD) | 72,891,261 | 81,876,868 | 20,911,704 | 93,026,917 | 95,951,499 | 116,013,364 | - | - | - |
| Operating Income (USD) | 71,643,933 | 80,756,941 | 20,661,410 | 92,166,379 | 94,991,332 | 114,799,349 | - | - | - |
| Operating Margin | 57.3% | 57.7% | 56.8% | 57.2% | 56.1% | 59.6% | - | - | - |
| % EBITDA Margin | 58.3% | 58.5% | 57.5% | 57.7% | 56.6% | 60.3% | - | - | - |
| NET Income (USD) | 57,761,034 | 65,044,978 | 14,131,034 | 64,107,316 | 72,082,276 | 107,041,134 | - | - | - |
| % Net Margin | 46.2% | 46.5% | 38.8% | 39.8% | 42.5% | 55.6% | - | - | - |
Sebia S.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Announced | Sebia S.A. | - | ||||||||
| Add-on | Completed | ZEUS Scientific, Inc. | - | ||||||||
| Add-on, Trade Sale | Completed | Orgentec Diagnostika GmbH | - | ||||||||
| Secondary Buyout | Completed | Sebia S.A. | - | ||||||||
| Secondary Buyout | Completed | Sebia S.A. | - |
Displaying 1 - 5 of 8
Sebia S.A. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.